Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Committee for Orphan Medicinal Products at the European Medicines Agency (EMA) has adopted a positive opinion recommending ...

European regulators recommended that a skin disease treatment developed by Vanda Pharmaceuticals receive orphan drug designation. Vanda said Thursday that the European Medicines Agency's Committee for ...

Vanda Pharma cash could be depleted by the end of 2027; multiple pipeline bets heighten both risk and opportunity. Read my ...

The designation covers VCA-894A, Vanda’s investigational treatment for Charcot-Marie-Tooth disease type 2S.

Principal Technologies Inc. (the "Company") announces that, further to its news releases dated April 28, 2025, July 28, 2025, and July 31, 2025, regarding the financing of its Licence of Technology ...

GreenShield, Canada's only national non-profit health care and insurance organization, has been named one of a select group of organizations recognized in Canadian HR Reporter Readers' Choice Awards ...

Detailed price information for Vanda Pharmaceuticals (VNDA-Q) from The Globe and Mail including charting and trades.

Rheumatologists and gastroenterologists don’t save their best drugs until last; neither should dermatologists.

In 12 to 16 percent of people with psoriasis, these patches appear on the palms or soles of feet. This is known as palmoplantar psoriasis. Most commonly, the type of psoriasis that affects the feet is ...

Brendan Camp, MD, FAAD, is a double board-certified dermatologist. A dermatologist may use your medical history and a physical exam to diagnose psoriasis. Psoriasis often appears purple or brown in ...

Topical medicines that are applied to the skin play an important role in the treatment of plaque psoriasis to help improve the appearance of the skin and reduce itching. New medicines that target the ...